EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC–induced murine hepatocarcinogenesis via centromere protein M

Yi Zhou, Shu Zhang, Guoteng Qiu, Xue Wang, Andrew Yonemura, Hongwei Xu, Guofei Cui, Shanshan Deng, Joanne Chun, Nianyong Chen, Meng Xu, Xinhua Song und 8 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci174415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Yi Zhou und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Signal Transduction, Proto-Oncogene Proteins c-akt, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activated mTORC2/AKT signaling plays a role in hepatocellular carcinoma (HCC). Research has shown that TSC/mTORC1 and FOXO1 are distinct downstream effectors of AKT signaling in liver regeneration and metabolism. However, the mechanisms by which these pathways mediate mTORC2/AKT activation in HCC are not yet fully understood. Amplification and activation of c-MYC are key molecular events in HCC. In this study, we explored the roles of tuberous sclerosis complex/mTORC1 (TSC/mTORC1) and FOXO1 as downstream effectors of mTORC2/AKT1 in c-MYC–induced hepatocarcinogenesis. Using various genetic approaches in mice, we found that manipulating the FOXO pathway had a minimal effect on c-MYC–induced HCC. In contrast, loss of mTORC2 inhibited c-MYC–induced HCC, an effect that was completely reversed by ablation of TSC2, which activated mTORC1. Additionally, we discovered that p70/RPS6 and 4EBP1/eIF4E acted downstream of mTORC1, regulating distinct molecular pathways. Notably, the 4EBP1/eIF4E cascade is crucial for cell proliferation and glycolysis in c-MYC–induced HCC. We also identified centromere protein M (CENPM) as a downstream target of the TSC2/mTORC1 pathway in c-MYC–driven hepatocarcinogenesis, and its ablation entirely inhibited c-MYC–dependent HCC formation. Our findings demonstrate that the TSC/mTORC1/CENPM pathway, rather than the FOXO cascade, is the primary signaling pathway regulating c-MYC–driven hepatocarcinogenesis. Targeting CENPM holds therapeutic potential for treating c-MYC–driven HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Signal TransductionProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-mycTuberous Sclerosis Complex 2 ProteinMechanistic Target of Rapamycin Complex 2Carcinoma, HepatocellularAnimalsMiceMultiprotein ComplexesChromosomal Proteins, Non-HistoneLiver NeoplasmsTumor Suppressor ProteinsForkhead Box Protein O1TOR Serine-Threonine KinasesLiver Neoplasms, ExperimentalMice, KnockoutCarcinogenesisCell Cycle Proteins

Stichwörter der Autor:innen

HepatologyLiver cancerMouse modelsOncologySignal transduction

Substanzen

Mechanistic Target of Rapamycin Complex 1Proto-Oncogene Proteins c-aktProto-Oncogene Proteins c-mycTuberous Sclerosis Complex 2 ProteinMechanistic Target of Rapamycin Complex 2Tsc2 protein, mouseAkt1 protein, mouseMyc protein, mouseMultiprotein ComplexesChromosomal Proteins, Non-Histone

Autor:innen und Institutionen

  • Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Bioengineering and Therapeutic Sciences and Liver Center, UCSF, San Francisco, California, USA.
  • Department of Head and Neck Oncology, Cancer Center.
  • Department of Radiation Oncology, Cancer Center.
  • Division of Liver Surgery, Department of General Surgery, and.
  • Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • NHGRI NIH HHS
  • NIGMS NIH HHS
  • NIMHD NIH HHS
  • National Institutes of Health
  • National Nature Science Foundation of China
  • Sichuan Science and Technology Program

Zitieren

APA

Zhou, Y., Zhang, S., Qiu, G., Wang, X., Yonemura, A., Xu, H., Cui, G., Deng, S., Chun, J., Chen, N., Xu, M., Song, X., Wang, J., Xu, Z., Deng, Y., Evert, M., Calvisi, D. F., Lin, S., Wang, H., & Chen, X. (2024). TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC–induced murine hepatocarcinogenesis via centromere protein M. Journal of Clinical Investigation. https://doi.org/10.1172/jci174415

Vancouver

Zhou Y, Zhang S, Qiu G, Wang X, Yonemura A, Xu H, et al. TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC–induced murine hepatocarcinogenesis via centromere protein M. Journal of Clinical Investigation. 2024. doi:10.1172/jci174415

BibTeX
@article{Zhou2024,
  author = {Zhou, Yi and Zhang, Shu and Qiu, Guoteng and Wang, Xue and Yonemura, Andrew and Xu, Hongwei and Cui, Guofei and Deng, Shanshan and Chun, Joanne and Chen, Nianyong and Xu, Meng and Song, Xinhua and Wang, Jingwen and Xu, Zijing and Deng, Youping and Evert, Matthias and Calvisi, Diego F and Lin, Shumei and Wang, Haichuan and Chen, Xin},
  title = {TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC–induced murine hepatocarcinogenesis via centromere protein M},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci174415}
}
Kostenlos starten →